3Dバイオプリンティング市場：コンポーネント、テクノロジー、エンドユーザー別-2025-2030年の世界予測

3Dバイオプリンティング市場の2023年の市場規模は17億9,000万米ドルで、2024年には21億4,000万米ドルに達すると予測され、CAGR 19.89％で成長し、2030年には63億9,000万米ドルに達すると予測されています。

3Dバイオプリンティングは、レイヤー・バイ・レイヤー法を用いて三次元構造を精密に作成し、生物学的・組織学的材料を製造することに焦点を当てた革新的技術です。3Dバイオプリンティングの必要性は、再生医療、医薬品、バイオエンジニアリングに革命をもたらす可能性によって定義され、移植可能な臓器の危機的な不足に対処し、正確な組織モデルによって医薬品開発を合理化し、患者に特化した治療をカスタマイズする能力から生まれます。その用途は、疾患モデリングのためのオルガノイドの作製から、インプラントや人工器官の製作まで多岐にわたり、最終用途には病院、研究機関、バイオテクノロジー企業などが含まれます。この市場に影響を与える主な成長要因としては、バイオマテリアルの進歩、研究開発資金の増加、革新的治療を必要とする慢性疾患の有病率の上昇などが挙げられます。最近の技術革新により、複雑な組織構造のバイオプリンティングや、ヒト組織を模倣したバイオインクを使用する機会が拡大しています。市場力学は、臨床的に実行可能な製品を開発するためのバイオプリンティング企業とヘルスケアプロバイダーとのコラボレーションによって推進され、政策や財政的インセンティブの形で政府の支援がさらなる拡大を促進しています。しかし、製造コストの高さ、スケーラビリティの問題、倫理的な懸念、迅速な商業化を阻む厳しい規制枠組などの制約があります。重大な障壁は、バイオプリント組織の脈管形成と長期的な機能性を達成することの技術的な難しさです。これらの課題に対処するためには、多材料・多細胞バイオプリンティング能力の開発、バイオインク製剤の改良、バイオプリンティングプロセスの自動化強化に向けた技術革新の舵取りが必要です。さらに、生物工学者、材料科学者、医療従事者が参加する学際的調査が、この分野の発展には不可欠です。組織工学、遺伝子編集の統合、個別化医療のフレームワークの開発といった新興国市場は成長のための肥沃な土壌を提供する一方、市場拡大のための有利な環境を育むためには、学界、産業界、規制機関の協力関係の育成が不可欠です。市場は黎明期でありながら急成長しており、継続的な技術革新と投資が、この変革期における潜在的機会を捉える鍵となります。

市場力学：急速に進化する3Dバイオプリンティング市場の主要市場インサイトを公開

3Dバイオプリンティング市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 疾患モデリングと組織工学に対する需要の高まり
  • 医薬品や錠剤の研究における3Dバイオプリンティング導入の増加
• 市場抑制要因
  • スケーラビリティと適切な印刷材料の入手性に関する懸念
• 市場機会
  • 博士課程の学術プロジェクトに提供される研究費の増加
  • 3Dバイオプリンタと生体材料の進歩の急増
• 市場の課題
  • 細胞生物学研究を行うには資金が必要

ポーターのファイブフォース：3Dバイオプリンティング市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：3Dバイオプリンティング市場における外部からの影響の把握

外部マクロ環境要因は、3Dバイオプリンティング市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析3Dバイオプリンティング市場における競合情勢の把握

3Dバイオプリンティング市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス3Dバイオプリンティング市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、3Dバイオプリンティング市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨3Dバイオプリンティング市場における成功への道筋を描く

3Dバイオプリンティング市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 疾患モデルと組織工学の需要の高まり
    • 医薬品や錠剤の調査における3Dバイオプリンティングの導入の増加
  • 抑制要因
    • 拡張性と適切な印刷材料の入手可能性に関する懸念
  • 機会
    • 博士課程の学術プロジェクトに提供される調査資金の増加
    • 3Dバイオプリンターとバイオマテリアルの進歩の急増
  • 課題
    • 細胞生物学調査を行うには多額の資本が必要
• 市場セグメンテーション分析
  • コンポーネント：さまざまな用途に適応できる3Dバイオプリンターの利用拡大
  • エンドユーザー：製薬会社およびバイオテクノロジー企業における3Dバイオプリンティングの使用が急増
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 3Dバイオプリンティング市場：コンポーネント別

• 3Dバイオプリンター
• バイオインク

第7章 3Dバイオプリンティング市場：技術別

• 押し出し法によるバイオプリンティング
• インクジェットベースのバイオプリンティング
• レーザーアシストバイオプリンティング

第8章 3Dバイオプリンティング市場：エンドユーザー別

• 製薬・バイオテクノロジー企業
• 調査機関

第9章 南北アメリカの3Dバイオプリンティング市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の3Dバイオプリンティング市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの3Dバイオプリンティング市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • Readily3D、複雑な組織の精密な印刷を可能にする先進的なバイオインクを発表
  • BIO INX、Rousselotと提携して3Dバイオプリンティング材料の進歩を目指す
  • Nexa3D、Essentiumの買収により市場規模を拡大
• 戦略分析と提言

企業一覧

• 3D BioFibR
• 3D Bioprinting Solutions
• 3D Systems Corporation
• Advanced Solutions, Inc.
• Aspect Biosystems Ltd.
• Avay Biosciences Private Limited
• Axiom Space, Inc.
• Axolotl Biosystems Ltd.
• BICO Group AB
• Brinter Inc.
• Cellbricks GmbH
• CollPlant Biotechnologies Ltd.
• Cyfuse Biomedical K.K.
• Desktop Metal, Inc.
• Fluicell AB
• FluidForm, Inc.
• FUJIFILM Corporation
• GE HealthCare Technologies Inc.
• GeSiM
• Inventia Life Science Pty Ltd.
• Medprin Regenerative Medical Technologies Co., Ltd.
• Merck KGaA
• Organovo Holdings Inc.
• Pandorum Technologies Pvt. Ltd.
• Precise Bio Inc.
• Prellis Biologics
• PrintBio, Inc
• REGEMAT 3D S.L.
• regenHU Ltd.
• Regenovo Biotechnology Co., Ltd. by Shining 3D Tech Co., Ltd.
• ROKIT Healthcare Inc.
• TheWell Bioscience Inc.
• UPM-Kymmene Corporation
• UpNano GmbH

LIST OF FIGURES

• FIGURE 1. 3D BIOPRINTING MARKET RESEARCH PROCESS
• FIGURE 2. 3D BIOPRINTING MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL 3D BIOPRINTING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL 3D BIOPRINTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL 3D BIOPRINTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL 3D BIOPRINTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL 3D BIOPRINTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS 3D BIOPRINTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS 3D BIOPRINTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES 3D BIOPRINTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES 3D BIOPRINTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC 3D BIOPRINTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC 3D BIOPRINTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA 3D BIOPRINTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA 3D BIOPRINTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. 3D BIOPRINTING MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. 3D BIOPRINTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. 3D BIOPRINTING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL 3D BIOPRINTING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL 3D BIOPRINTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL 3D BIOPRINTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. 3D BIOPRINTING MARKET DYNAMICS
• TABLE 7. GLOBAL 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL 3D BIOPRINTING MARKET SIZE, BY 3D BIOPRINTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL 3D BIOPRINTING MARKET SIZE, BY BIOINKS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL 3D BIOPRINTING MARKET SIZE, BY EXTRUSION-BASED BIOPRINTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL 3D BIOPRINTING MARKET SIZE, BY INKJET-BASED BIOPRINTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL 3D BIOPRINTING MARKET SIZE, BY LASER-ASSISTED BIOPRINTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL 3D BIOPRINTING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL 3D BIOPRINTING MARKET SIZE, BY RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. AMERICAS 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS 3D BIOPRINTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 21. ARGENTINA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 22. ARGENTINA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 24. BRAZIL 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 25. BRAZIL 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 26. BRAZIL 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 27. CANADA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 28. CANADA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 29. CANADA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 30. MEXICO 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 31. MEXICO 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 32. MEXICO 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 33. UNITED STATES 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 34. UNITED STATES 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES 3D BIOPRINTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 37. ASIA-PACIFIC 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 38. ASIA-PACIFIC 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC 3D BIOPRINTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 41. AUSTRALIA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 42. AUSTRALIA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 43. AUSTRALIA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 44. CHINA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 45. CHINA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 46. CHINA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 47. INDIA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 48. INDIA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 49. INDIA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 50. INDONESIA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 51. INDONESIA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 52. INDONESIA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 53. JAPAN 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 54. JAPAN 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 55. JAPAN 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 56. MALAYSIA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 57. MALAYSIA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 58. MALAYSIA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 59. PHILIPPINES 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 60. PHILIPPINES 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 61. PHILIPPINES 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 62. SINGAPORE 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 63. SINGAPORE 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 64. SINGAPORE 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 65. SOUTH KOREA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 66. SOUTH KOREA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 67. SOUTH KOREA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 68. TAIWAN 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 69. TAIWAN 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 70. TAIWAN 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 71. THAILAND 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 72. THAILAND 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 73. THAILAND 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 74. VIETNAM 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 75. VIETNAM 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 76. VIETNAM 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 77. EUROPE, MIDDLE EAST & AFRICA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 78. EUROPE, MIDDLE EAST & AFRICA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA 3D BIOPRINTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 81. DENMARK 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 82. DENMARK 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 83. DENMARK 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 84. EGYPT 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 85. EGYPT 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 86. EGYPT 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 87. FINLAND 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 88. FINLAND 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 89. FINLAND 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 90. FRANCE 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 91. FRANCE 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 92. FRANCE 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 93. GERMANY 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 94. GERMANY 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 95. GERMANY 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 96. ISRAEL 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 97. ISRAEL 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 98. ISRAEL 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 99. ITALY 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 100. ITALY 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 101. ITALY 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 102. NETHERLANDS 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 103. NETHERLANDS 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 104. NETHERLANDS 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 105. NIGERIA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 106. NIGERIA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 107. NIGERIA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 108. NORWAY 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 109. NORWAY 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 110. NORWAY 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 111. POLAND 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 112. POLAND 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 113. POLAND 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 114. QATAR 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 115. QATAR 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 116. QATAR 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 117. RUSSIA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 118. RUSSIA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 119. RUSSIA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 120. SAUDI ARABIA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 121. SAUDI ARABIA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 122. SAUDI ARABIA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 123. SOUTH AFRICA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 124. SOUTH AFRICA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH AFRICA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 126. SPAIN 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 127. SPAIN 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 128. SPAIN 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 129. SWEDEN 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 130. SWEDEN 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 131. SWEDEN 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 132. SWITZERLAND 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 133. SWITZERLAND 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 134. SWITZERLAND 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 135. TURKEY 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 136. TURKEY 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 137. TURKEY 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 138. UNITED ARAB EMIRATES 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 139. UNITED ARAB EMIRATES 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 140. UNITED ARAB EMIRATES 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 141. UNITED KINGDOM 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 142. UNITED KINGDOM 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 143. UNITED KINGDOM 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 144. 3D BIOPRINTING MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 145. 3D BIOPRINTING MARKET, FPNV POSITIONING MATRIX, 2023

The 3D Bioprinting Market was valued at USD 1.79 billion in 2023, expected to reach USD 2.14 billion in 2024, and is projected to grow at a CAGR of 19.89%, to USD 6.39 billion by 2030.

3D bioprinting is an innovative technology focused on the precise creation of three-dimensional structures using a layer-by-layer method to produce biological and tissue-like materials. Defined by its potential to revolutionize regenerative medicine, pharmaceuticals, and bioengineering, the necessity of 3D bioprinting arises from its ability to address critical shortages in transplantable organs, streamline drug development with accurate tissue models, and customize patient-specific treatments. Its applications span from fabricating organoids for disease modeling to crafting implants and prosthetics, with end-use segments including hospitals, research institutions, and biotechnology companies. Key growth factors influencing this market include advancements in biomaterials, increased funding for R&D, and the rising prevalence of chronic diseases necessitating innovative treatments. Recent technological breakthroughs have expanded opportunities in bioprinting complex tissue structures and using bioinks mimicking human tissues. Market dynamics are propelled by collaborations between bioprinting firms and healthcare providers to develop clinically viable products, while governmental support in the form of policies and financial incentives facilitates further expansion. However, limitations include high manufacturing costs, scalability issues, ethical concerns, and stringent regulatory frameworks that challenge rapid commercialization. A significant barrier remains the technical difficulty in achieving vascularization and long-term functionality of bioprinted tissues. Addressing these challenges involves steering innovation towards developing multi-material and multicellular bioprinting capabilities, refining bioink formulations, and enhancing automation in bioprinting processes. Furthermore, interdisciplinary research involving bioengineers, material scientists, and medical practitioners is crucial for advancing this field. Emerging areas such as tissue engineering, gene editing integration, and the development of personalized medicine frameworks offer fertile ground for growth, while fostering collaboration among academia, industry, and regulatory bodies is essential to nurture a favorable environment for market expansion. With the market in a nascent yet rapidly growing stage, continuous innovation and investment are key to capturing potential opportunities in this transformative landscape.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving 3D Bioprinting Market

The 3D Bioprinting Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising demand for disease modeling and tissue engineering
  • Increase in deployment of 3D bioprinting across research of drugs and pills
• Market Restraints
  • Concern over scalability and availability of suitable printing materials
• Market Opportunities
  • Increasing research funding provided to doctoral academic projects
  • Proliferation in advancements of 3D bioprinters and biomaterials
• Market Challenges
  • Capital intensive to perform cell biology research

Porter's Five Forces: A Strategic Tool for Navigating the 3D Bioprinting Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the 3D Bioprinting Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the 3D Bioprinting Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the 3D Bioprinting Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the 3D Bioprinting Market

A detailed market share analysis in the 3D Bioprinting Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the 3D Bioprinting Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the 3D Bioprinting Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the 3D Bioprinting Market

A strategic analysis of the 3D Bioprinting Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the 3D Bioprinting Market, highlighting leading vendors and their innovative profiles. These include 3D BioFibR, 3D Bioprinting Solutions, 3D Systems Corporation, Advanced Solutions, Inc., Aspect Biosystems Ltd., Avay Biosciences Private Limited, Axiom Space, Inc., Axolotl Biosystems Ltd., BICO Group AB, Brinter Inc., Cellbricks GmbH, CollPlant Biotechnologies Ltd., Cyfuse Biomedical K.K., Desktop Metal, Inc., Fluicell AB, FluidForm, Inc., FUJIFILM Corporation, GE HealthCare Technologies Inc., GeSiM, Inventia Life Science Pty Ltd., Medprin Regenerative Medical Technologies Co., Ltd., Merck KGaA, Organovo Holdings Inc., Pandorum Technologies Pvt. Ltd., Precise Bio Inc., Prellis Biologics, PrintBio, Inc, REGEMAT 3D S.L., regenHU Ltd., Regenovo Biotechnology Co., Ltd. by Shining 3D Tech Co., Ltd., ROKIT Healthcare Inc., TheWell Bioscience Inc., UPM-Kymmene Corporation, and UpNano GmbH.

Market Segmentation & Coverage

This research report categorizes the 3D Bioprinting Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Component, market is studied across 3D Bioprinters and Bioinks.
• Based on Technology, market is studied across Extrusion-based Bioprinting, Inkjet-based Bioprinting, and Laser-assisted Bioprinting.
• Based on End-user, market is studied across Pharmaceutical & Biotechnology Companies and Research Organizations.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising demand for disease modeling and tissue engineering
    • 5.1.1.2. Increase in deployment of 3D bioprinting across research of drugs and pills
  • 5.1.2. Restraints
    • 5.1.2.1. Concern over scalability and availability of suitable printing materials
  • 5.1.3. Opportunities
    • 5.1.3.1. Increasing research funding provided to doctoral academic projects
    • 5.1.3.2. Proliferation in advancements of 3D bioprinters and biomaterials
  • 5.1.4. Challenges
    • 5.1.4.1. Capital intensive to perform cell biology research
• 5.2. Market Segmentation Analysis
  • 5.2.1. Component: Proliferating utilization of the 3D bioprinters capable of adapting to a range of applications
  • 5.2.2. End-user: Burgeoning usage of the 3D bioprinting across the pharmaceutical & biotechnology companies
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. 3D Bioprinting Market, by Component

• 6.1. Introduction
• 6.2. 3D Bioprinters
• 6.3. Bioinks

7. 3D Bioprinting Market, by Technology

• 7.1. Introduction
• 7.2. Extrusion-based Bioprinting
• 7.3. Inkjet-based Bioprinting
• 7.4. Laser-assisted Bioprinting

8. 3D Bioprinting Market, by End-user

• 8.1. Introduction
• 8.2. Pharmaceutical & Biotechnology Companies
• 8.3. Research Organizations

9. Americas 3D Bioprinting Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific 3D Bioprinting Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa 3D Bioprinting Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. Readily3D Unveils Advanced Bio-Inks for Precision 3D Bioprinting of Complex Tissues
  • 12.3.2. BIO INX Partners with Rousselot for Advancements in 3D Bioprinting Materials
  • 12.3.3. Nexa3D Expands Market Footprint with the Acquisition of Essentium
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. 3D BioFibR
• 2. 3D Bioprinting Solutions
• 3. 3D Systems Corporation
• 4. Advanced Solutions, Inc.
• 5. Aspect Biosystems Ltd.
• 6. Avay Biosciences Private Limited
• 7. Axiom Space, Inc.
• 8. Axolotl Biosystems Ltd.
• 9. BICO Group AB
• 10. Brinter Inc.
• 11. Cellbricks GmbH
• 12. CollPlant Biotechnologies Ltd.
• 13. Cyfuse Biomedical K.K.
• 14. Desktop Metal, Inc.
• 15. Fluicell AB
• 16. FluidForm, Inc.
• 17. FUJIFILM Corporation
• 18. GE HealthCare Technologies Inc.
• 19. GeSiM
• 20. Inventia Life Science Pty Ltd.
• 21. Medprin Regenerative Medical Technologies Co., Ltd.
• 22. Merck KGaA
• 23. Organovo Holdings Inc.
• 24. Pandorum Technologies Pvt. Ltd.
• 25. Precise Bio Inc.
• 26. Prellis Biologics
• 27. PrintBio, Inc
• 28. REGEMAT 3D S.L.
• 29. regenHU Ltd.
• 30. Regenovo Biotechnology Co., Ltd. by Shining 3D Tech Co., Ltd.
• 31. ROKIT Healthcare Inc.
• 32. TheWell Bioscience Inc.
• 33. UPM-Kymmene Corporation
• 34. UpNano GmbH